All ProductsDisplaying Products by Catalog Number (7500 - 7599)
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900800081008200830084008500860087008800
Cat. No. | Product Name / Activity |
---|---|
7503 | MD13 |
Potent MIF Degrader (PROTAC®) | |
7504 | MD15 |
Negative control for MD13 (Cat. No. 7503) | |
7505 | PLpro inhibitor 19 |
SARS-CoV-2 PLpro and replication inhibitor | |
7506 | Click N-Acetylmuramic acid - azide |
Bacterial peptidoglycan derivative; suitable for 'click'-conjugation to fluorescent dyes | |
7507 | Evofosfamide |
Hypoxia-activated DNA alkylating agent prodrug | |
7508 | EMD 527040 hydrochloride |
ανβ6 integrin inhibitor | |
7509 | NR12S |
Fluorogenic lipid membrane dye. Used for: staining lipid at the outer leaflet of vesicles and cell membranes, suitable for live cell imaging. Application: fluorescence microscopy | |
7510 | Indocyanine green |
Near-infrared (NIR) fluorescent dye; suitable for in vivo imaging | |
7511 | ARN 3236 |
Potent inhibitor of salt-inducible kinases | |
7512 | 3-Bromopyruvate |
MCT1 inhibitor; also inhibits hexokinase II | |
7513 | Lenalidomide 4'-PEG1-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
7514 | Lenalidomide 4'-PEG2-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
7516 | Lenalidomide 4'-alkylC3-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7517 | Lenalidomide 4'-alkylC5-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7518 | Thalidomide 4'-ether-PEG1-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
7519 | Thalidomide 4'-ether-PEG2-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
7520 | Thalidomide 4'-ether-PEG3-azide |
Cereblon ligand with PEG linker and terminal azide for onward chemistry | |
7521 | Thalidomide 4'-ether-alkylC3-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7522 | Thalidomide 4'-ether-alkylC5-azide |
Cereblon ligand with alkyl linker and terminal azide for onward chemistry | |
7523 | TSA Vivid™ Fluorophore Kit 520 |
Signal amplification kit for use in ISH, ICC and IHC | |
7524 | Biotin-PEG3-Azide |
Biotin with PEG linker and reactive click handle | |
7525 | dCeMM2 |
Molecular glue Degrader; induces ubiquitination and degradation of cyclin K | |
7526 | TSA Vivid™ Fluorophore Kit 570 |
Signal amplification kit for use in ISH, ICC and IHC | |
7527 | TSA Vivid™ Fluorophore Kit 650 |
Signal amplification kit for use in ISH, ICC and IHC | |
7528 | BSJ-4-116 |
Selective CDK12 PROTAC® Degrader | |
7529 | BSJ-4-116-NC |
Negative control for BSJ-4-116 (Cat. No. 7528) | |
7530 | dTAG-47 |
Degrades mutant FKBP12F36V fusion proteins; useful alternative to genetic methods for target validation | |
7531 | dTAG-47-NEG |
Negative control for dTAG-47 (Cat. No. 7530) | |
7532 | CSN5i-3-NEG |
Negative control for CSN5i-3 (Cat. No. 7089) | |
7533 | ZE 132 |
Potent and selective PD-1/PD-L1 interaction inhibitor | |
7538 | NBD-PE |
Green-fluorescent label for lysosomal lipid bodies. Used for: Application: confocal microscopy | |
7541 | Helianorphin-19 |
Potent and selective G protein-biased κ opioid receptor (KOR) agonist | |
7542 | SJ 1008066 |
MAGE-A11 inhibitor; disrupts MAGE-A11:PCF11 interaction | |
7544 | SiRA 2 |
Fluorogen for SiRA light-up aptamer. Application: confocal microscopy, SRM (including STED) | |
7546 | C28 |
Potent LMTK3 inhibitor | |
7549 | BAY 1816032 |
Potent and selective BUB1 kinase inhibitor | |
7551 | NCT 02 |
Molecular glue; induces degradation of CCNK and CDK12 | |
7553 | Ac4ManNDAz |
Photo-crosslinking probe for studying glycoproteins and glycolipids | |
7554 | SSYA10-001 |
Potent coronavirus helicase inhibitor; also inhibits human papillomavirus E6 | |
7555 | SenTraGor™ |
Reagent for staining and detection of lipofuscin in senescent cells | |
7556 | ALDH Detection Reagent - BAAA-DA |
Fluorescent ALDH substrate and detection reagent. Used for: identification of cells with high ALDH activity. Application: flow cytometry, fluorescent-activated cell sorting (FACS) | |
7557 | Thalidomide 5'-amine-alkylC8-amine |
Cereblon ligand with alkyl linker and terminal amine for onward chemistry | |
7558 | SRT 1720 |
Selective SIRT1 activator; induces autophagy and mitochondrial biogenesis | |
7561 | G6PDi 1 |
Potent, reversible glucose-6-phosphate dehydrogenase (G6PD) inhibitor | |
7563 | Tissue Clearing Pro Reagent 1 |
Tissue clearing reagent | |
7566 | VH 032 amide-alkylC9-amine |
VHL ligand with alkyl linker and terminal amine for onward chemistry | |
7568 | VH 032 amide-PEG6-amine |
VHL ligand with PEG linker and terminal amine for onward chemistry | |
7569 | Verdinexor |
Selective exportin-1 (XPO1/CRM1) inhibitor | |
7570 | T3 CLK |
Potent and selective pan-CLK inhibitor; also inhibits DYRK1A/B | |
7572 | NR 162 |
Potent and selective calcium/calmodulin-dependent serine protein kinase (CASK) inhibitor | |
7573 | BAY 1797 |
Selective P2X4 antagonist | |
7575 | aTAG 2139-NEG |
Negative control for aTAG 2139 (Cat. No. 6970) | |
7576 | (+)-JQ1 maleimide |
JQ1-maleimide functionalized probe; induces proteasomal degradation of BRD4 | |
7577 | 3-Mercaptopicolinic acid hydrochloride |
Phospoenolpyruvate carboxykinase (PEPCK) inhibitor; inhibits gluconeogenesis | |
7578 | Tocriscreen Epigenetics 3.0 |
A library of 160 epigenetic compounds (100 μL, 10 mM DMSO solutions) for high throughput screening, high content screening, target validation and assay development | |
7579 | Olaparib |
Potent PARP inhibitor | |
7580 | WIC1 |
Inhibitor of Wnt/β-catenin signaling | |
7583 | SK 575 |
Potent PARP1 Degrader (PROTAC®) | |
7584 | iP300v |
Negative control for iP300w (Cat. No. 7270) | |
7586 | Molnupiravir |
Prodrug of antiviral nucleoside analog; inhibits SARS-CoV, SARS-CoV-2 and MERS-CoV infection | |
7588 | SK 575-NEG |
Negative control for SK 575 (Cat. No. 7583) | |
7589 | Adavosertib |
Potent and selective Wee1 inhibitor | |
7590 | Pexidartinib |
Potent CSF-1R inhibitor | |
7591 | CB 839 |
Potent glutaminase GLS1 inhibitor |